IDEAS home Printed from https://ideas.repec.org/a/oup/scippl/v31y2004i5p371-383.html
   My bibliography  Save this article

Commercialisation of biotechnology: Do dedicated public policies matter?

Author

Listed:
  • Christien Enzing
  • Annelieke van der Giessen
  • Sander Kern

Abstract

National governments are often confronted with the questions whether generic policy instruments are sufficient to support technology development and innovation and what justifies the introduction of instruments that focus on one specific technology. This article investigates the relationship between the commercial performance in biotechnology of 14 EU Member States and the presence of instruments that stimulate and support commercialisation of biotechnology in these countries. Our findings contradict the proposition that countries with dedicated biotech instruments show better commercialisation performance in biotechnology than countries without such instruments. Instead, success is more likely to be determined by the systemic character of public policies that address all elements of the innovation system, including instruments that stimulate the life sciences knowledge base and its commercialisation. Copyright , Beech Tree Publishing.

Suggested Citation

  • Christien Enzing & Annelieke van der Giessen & Sander Kern, 2004. "Commercialisation of biotechnology: Do dedicated public policies matter?," Science and Public Policy, Oxford University Press, vol. 31(5), pages 371-383, October.
  • Handle: RePEc:oup:scippl:v:31:y:2004:i:5:p:371-383
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.3152/147154304781779868
    Download Restriction: Access to full text is restricted to subscribers.
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Rodriguez, Victor & Janssens, Frizo & Debackere, Koenraad & De Moor, Bart, 2008. "On material transfer agreements and visibility of researchers in biotechnology," Journal of Informetrics, Elsevier, vol. 2(1), pages 89-100.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:oup:scippl:v:31:y:2004:i:5:p:371-383. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Oxford University Press (email available below). General contact details of provider: https://academic.oup.com/spp .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.